Rabies is a deadly viral disease transmitted through the saliva of infected animals. It affects the central nervous system, leading to severe neurological symptoms and ultimately death if left untreated. Vaccination remains the most effective preventive measure against rabies, and ERAVAC is a widely used rabies vaccine in South Africa.
Image: vets.blog.gov.uk
Understanding ERAVAC and its Composition:
ERAVAC is an inactivated rabies vaccine produced by the South African Veterinary Institute (SAVI). It contains inactivated rabies virus grown in Vero cells, a type of cell line derived from African green monkey kidney tissue. The virus is chemically inactivated to eliminate its infectivity, ensuring its safety for use in animals.
Immunogenicity and Efficacy of ERAVAC:
ERAVAC is highly immunogenic, inducing a strong immune response against rabies virus. Studies have shown that a single dose of ERAVAC can provide long-lasting protection for up to three years in dogs and cats.
Its efficacy has been proven in field trials, where vaccinated animals remained protected from rabies when exposed to the virus. ERAVAC is particularly beneficial in areas with a high risk of rabies transmission, such as rural communities and regions with wildlife reservoirs of the virus.
Dosage and Administration of ERAVAC:
ERAVAC is typically administered subcutaneously, with a single dose of 1 ml being sufficient to provide protection. In primary vaccination, puppies and kittens should receive two doses, with the second dose given 2-4 weeks after the first. Adult animals require only a single booster dose every three years to maintain immunity.
It is essential to follow the recommended vaccination schedule to ensure optimal protection against rabies. Owners should consult with their veterinarian for personalized vaccination advice based on their animal’s age, species, and risk factors.
Image: www.rabieswatch.com
Additional Features and Advantages of ERAVAC:
- Heat Stability: ERAVAC exhibits good heat stability, making it suitable for storage and transportation in challenging conditions.
- Safety Profile: The vaccine has a favorable safety profile, with minimal side effects typically limited to mild injection site reactions.
- WHO Pre-Qualification: ERAVAC is pre-qualified by the World Health Organization (WHO), a testament to its quality and adherence to international standards.
Rabies Vaccine South Africa Trade Name
Conclusion:
ERAVAC is a dependable rabies vaccine that plays a crucial role in rabies prevention and control in South Africa. It offers effective protection, a favorable safety profile, and ease of administration. By vaccinating animals with ERAVAC, veterinarians and pet owners can contribute to reducing the risk of rabies transmission and safeguarding public health.
